NCT00001873View on ClinicalTrials.gov

The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers

PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 22, 1999

Primary Completion Date

December 28, 2007

Study Completion Date

June 13, 2017

Conditions
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHematologic NeoplasmMultiple MyelomaMyelodysplastic Syndrome
Interventions
DEVICE

Isolex 300i plus MoAbs

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001873 - The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers | Biotech Hunter | Biotech Hunter